Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of CAT-354

NCT00640016 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00640016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of CAT-354
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2008
Completion date
July 31, 2008
Enrollment
14 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

asthma